GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Harbor Diversified HRBR · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.36

-1.67%

Close of 19 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Harbor Diversified — daily HRBR Delayed
Market value
$103.9m
Last close × shares
Volume
707
Shares, 19 Nov 2026

About Harbor Diversified

Its shares trade under the ticker HRBR. It has been listed since 8 September 1997. In the fiscal year to 31 December 2024, it reported revenue of $199.2m and a net loss of $16.0m. At that date it held total assets of $236.3m and shareholders' equity of $176.6m.

Harbor Diversified, Inc. is a development stage pharmaceutical company, which engages in the discovery, development, and commercialization of products for the treatment of diseases related to aging. The company is headquartered in Appleton, Wisconsin. The company is engaged in the discovery and development of products for the treatment of diseases that typically onset with age. The company is primarily focused on the development of a series of hormone-related sterols that are derived from the human adrenal metabolome. The firm is development-stage company with two product candidates: Apoptone (HE3235) in patients with late-stage prostate cancer, and Triolex (HE3286) in obese type-2 diabetes mellitus patients. The firm focuses on the development of synthetic sterol derivatives derived from the human 19-carbon steroid scaffold of the mammalian sterol metabolome. The company has conducted clinical trials with its drug development candidates, which include Apoptone (HE3235); Triolex (HE3286); Neumune (HE2100), for the treatment of sepsis, and HE2000, for the prevention of opportunistic infections in immune-suppressed patients.

Figures and description from our data supplier, not checked against the company's own report.

More about Harbor Diversified →

How it makes its money

Revenue, year to 31 Dec 2021

  • Contract Revenue [Member] $247.5m · 100.0%
  • Contract Service and Other Member $60,000 · 0.0%

Latest on Harbor Diversified

Our reporting

We have not reported on Harbor Diversified yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Harbor Diversified's ticker?

Harbor Diversified trades as HRBR on its US listing, under ISIN US41150R1023.

What was Harbor Diversified's last closing price?

2.36 on 19 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.